DOJ’s Bulk Sensitive Personal Data Rule: A Cross-Border Compliance Imperative for the Life Sciences Industry

Part II: Transferring Data Safely: National Security, Privacy, and Emerging Sovereign Rights

Cross-border data flows in the life sciences sector sit at the crossroads of national security enforcement, evolving privacy law, and a new

Federal Court Rules DOJ Bulk Sensitive Data Regulations Open New Path for ECPA Privacy Lawsuits

On June 16, 2026, the Northern District of Illinois became the first court to consider how the DOJ’s Bulk Sensitive Data (BSD) rule affects

US biotechs turn secretive as they fear competition from rising Chinese industry

US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell End

China Compliance Update: Life Sciences — Spring 2026

In 2026, Chinese regulators have continued their focus on anti-corruption enforcement in the life sciences industry. In addition to long-sta

EDPB/EDPS Joint Opinion on the European Biotech Act Proposal: Key Data Protection Implications for Pharma and Life Sciences

Fall 2016 Cross-border Data Privacy Issues

The symposium examines the challenges and complexities of cross-border data transfers, particularly between the EU and the US, highlighting